Digital Oral Presentation Session 1 - Epidemiology, environment and nutrition

  • 17:45-18:45 Digital Oral Presentation Session 1 – Epidemiology, environment and nutrition
    Chair:
    Ebbe Langholz, Hellerup, Denmark
    Peter Lakatos, Budapest, Hungary; Montreal, Canada
      17:45-17:51 DOP001:  European Crohn’s and Colitis Organisation topical review on environmental factors in IBD

    Maaser, C.
    1, Langholz, E.2, Gordon, H.3, Burisch, J.4, Ellul, P.5, Hernández, V.6, Karakan, T.7, Katsanos, K.H.8, Krustins, E.9, Levine, A.10, Mantzaris, G.J.11, O’Morain, C.12, Yuksel, E.S.13, Strid, H.14, Annese, V.15

    1Klinikum Lueneburg, Lueneburg, Germany, 2Department C, Gastroenterology Section, Herlev and  Gentofte  University Hospital, Hellerup, Denmark, 3Department of Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom, 4Department of Gastroenterology, North Zealand University Hospital, Fredrikssund, Denmark, 5Department of Gastroenterology, Division of Gastroenterology, Mater Dei Hospital, Msida, Malta, 6Department of Gastroenterology, Hospital Álvaro Cunqueiro, Vigo, Spain, 7Department of Gastroenterology, Ankara, Turkey, 8Department of Gastroenterology and Hepatology, University and Medical School of Ioannina, Ioannina, Greece, 9Department of Gastroenterology, Hepatology and Nutrition Therapy, Pauls Stradins Clinical University Hospital, Riga, Latvia, 10Paediatric Gastroenterology & Nutrition Unit, Wolfson Medical Center, Tel Aviv, Israel, 11Department of Gastroenterology, Evangelismos Hospital, Athens, Greece, 12Department of Gastroenterology, Dublin, Ireland, 13Department of Gastroenterology, Izmir Katip Celebi University, Izmir, Turkey, 14Department of Internal Medicine, Södra Älvsborgs Hospital, Borås, Sweden, 15Department of Emergency, Division of Gastroenterology, University Hospital Careggi, Florence, Italy
      17:51-17:57 DOP002: Trends in small bowel resections for Crohn’s Disease with and without short bowel syndrome in the era of biologics

    Limketkai, B.1, Parian, A.2, Colombel, J.-F.3
    1Stanford University School of Medicine, Gastroenterology & Hepatology, Stanford, California, United States, 2Johns Hopkins University School of Medicine, Gastroenterology & Hepatology, Baltimore, Maryland, United States, 3Icahn School of Medicine at Mount Sinai, Division of Gastroenterology, New York, New York, United States
      17:57-18:03 DOP003: Proximal disease extension in patients with limited Ulcerative Colitis: A Danish population-based inception cohort

    Burisch, J.1, Vind, I.2, Prosberg, M.2, Colombel, J.-F.3, Ungaro, R.3, Bendtsen, F.2, Vester-Andersen, M.2,4

    1North Zealand University Hospital, Department of Gastroenterology, Frederikssund, Denmark, 2Hvidvore University Hospital, Gastrounit, medical section, Hvidovre, Denmark, 3Susan and Leonard Feinstein IBD Clinical Center Icahn School of Medicine at Mount Sinai, Departments of Medicine and Pediatrics, New York, United States, 4Zealand University Hospital, Department of Medical Gastroenterology, Køge, Denmark
      18:03-18:09 DOP004: Ethnicity and country of birth are associated with phenotypic differences in patients with Inflammatory Bowel Disease

    Spekhorst, L.
    1,2, Severs, M.3, de Boer, N.K.H.4, Festen, E.A.M.1,2, Fidder, H.H.3, Hoentjen, F.5, Imhann, F.1,2, de Jong, D.J.5, van der Meulen-de Jong, A.E.6, Pierik, M.7, van der Woude, C.J.8, Dijkstra, G.1, Ponsioen, C.Y.9, Lowenberg, M.9, Oldenburg, B.3, Weersma, R.K.1

    1University of Groningen and University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, Netherlands, 2University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, Netherlands, 3University Medical Center Utrecht, Department of Gastroenterology and Hepatology, Utrecht, Netherlands, 4VU University Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, Netherlands, 5University Medical Center St. Radboud, Department of Gastroenterology and Hepatology, Nijmegen, Netherlands, 6Leiden University Medical Center, Department of Gastroenterology and Hepatology, Leiden, Netherlands, 7University Medical Center Maastricht, Division of Gastroenterology and Hepatology, Maastricht, Netherlands, 8Erasmus Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, Netherlands, 9Amsterdam Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, Netherlands
      18:09-18:15 DOP005: Proximal disease extension in limited Ulcerative Colitis: A systematic review and meta-analysis

    Roda, G.
    1, Narula, N.2, Pinotti, R.3, Skamnelos, A.4, Katsanos, K.4, Torres, J.5, Ungaro, R.6, Colombel, J.-F.7

    1University of Bologna, Gastroenterology, BOLOGNA, Italy, 2University of Toronto, Canada, Gastroenterology, Toronto, Canada, 3Icahn School of Medicine, Levy Library, New York, United States, 4University Hospital of Ioannina - Greece, Department of Gastroenterology, Ioannina, Greece, 5Icahn School of Medicine, Gastroenterology, New York, United States, 6Icahn School of Medicine at Mount Sinai, Department of Gastroenterology, New York, United States, 7Icahn School of Medicine at Mount Sinai, Division of Gastroenterology, New York, New York, United States
       18:15-18:21 DOP006: Research gaps in diet and nutrition in Inflammatory Bowel Disease. A topical review by ECCO

    Sigall Boneh, R.1, Levine, A.1,2, Lomer, M.3, Wierdsma, N.4, Alan, P.5, Fiorino, G.6, Gatti, S.7, Jonkers, D.8, Kierkus, J.9, H. Katsanos, K.10, Melgar, S.11, Saritas Yuksel, E.12, Whelan, K.13, Wine, E.14, Gerasimidis, K.15

    1Wolfson Medical Center, Pediatric Gastroenterology and Nutrition Unit, Tel Aviv, Israel, 2Tel Aviv University, Tel Aviv, Israel, 3Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, Department of Nutrition and Dietetics, London, United Kingdom, 4VU University Medical Centre, Department of Nutrition and Dietetics,, Amsterdam, Netherlands, 5John Radcliffe Hospital, Department of Translational Gastroenterology, Oxford, United Kingdom, 6Humanitas Research Hospital, , Department of Gastroenterology, IBD Center, Rozzano, Italy, 7Polytechnic University of Marche, Department of Paediatrics, Ancona, Italy, 8NUTRIM School for Nutrition and Translation Research in Metabolism, Maastricht University Medical Center, Division Gastroenterology-Hepatology, Department of Internal Medicine, Maastricht, Netherlands, 9Children’s Memorial Health Institute, Department of Gastroenterology, Hepatology, Feeding Disorders and Pediatrics, Warsaw, Poland, 10University and Medical School of Ioannina, Department of Gastroenterology and Hepatology, Ioannina, Greece, 11APC Microbiome Institute, University College Cork, Cork, Ireland, 12Izmir Katip Celebi University Ataturk Teaching and Research Hospital, Department of Gastroenterology, Izmir, Turkey, 13King’s College London,, Division of Diabetes and Nutritional Sciences, London, United Kingdom, 14University of Alberta, Department of Paediatrics, Edmonton, Canada, 15University of Glasgow, Human Nutrition, School of Medicine, Dentistry and Nursing, Glasgow, United Kingdom
       18:21-18:27 DOP007: Crohn's Disease exclusion diet and partial enteral nutrition (CDED+PEN) vs. exclusive enteral nutrition (EEN): Microbiome changes of a randomized clinical trial (RCT) in pediatric CD: Remission in associated with similar structural + functional profiles

    Dunn, K.A.1, Sigall-Boneh, R.2, Bielawski, J.P.1, Turner, D.3, Van Limbergen, J.4, Levine, A.2

    1Dalhousie University, Biology, Halifax, Canada, 2Edith Wolfson Medical Centre, Pediatrics, Tel Aviv, Israel, 3Shaare Zedek Medical Center, Department of Gastroenterology and Digestive Diseases, Jerusalem, Israel, 4IWK Health Centre - Dalhousie University, Pediatric Gastroenterology, Halifax, Canada
      18:27-18:33 DOP008: Dietary manipulation of the healthy human and Colitic murine gut microbiome by CD-TREAT diet and exclusive enteral nutrition; a proof of concept study

    Svolos, V.1, Hansen, R.2, Ijaz, U.Z.3, Quince, C.4, Watson, D.5, Alghamdi, A.5, Brejnrod, A.4, Ansalone, C.6, Milling, S.6, Gaya, D.7, Russell, R.2, Gerasimidis, K.1

    1Human Nutrition, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Royal Infirmary, Glasgow, United Kingdom, 2Department of Paediatric Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children, Glasgow, United Kingdom, 3School of Engineering, University of Glasgow, Glasgow, United Kingdom, 4Warwick Medical School, University of Warwick, Warwick, United Kingdom, 5Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom, 6Institute of Infection, Immunity and Inflammation, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom, 7Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, United Kingdom
      18:33-18:39 DOP009: Choice of corticosteroids or exclusive enteral nutrition as the first induction of remission therapy does not affect disease behavior within two years of diagnosis

    Cohen - Dolev, N.1
    , Sladek, M.2, Sigall Boneh, R.1, Veres, G.3, Hussey, S.4, Staiano, A.5, Nuti, F.6, Lionetti, P.7, Koletzko, S.8, Levine, A.1

    1The E.Wolfson medical Center, Pediatric Gastroenterology and Nutrition Research Unit, Holon, Israel, 2Jagiellonian University Medical College, Krakow, Poland, 3Semmelweis University, Ist Dept. of Pediatrics, Budapest, Hungary, 4National Children's Research Centre, UCD and RCSI, Dublin, Ireland, 5University of Naples “Federico II”., Department of Translational Medical Science, Section of Pediatrics, Napoli, Italy, 6Sapienza University, Rome, Italy, 7University of Florence, Florence, Italy, 8Dr. v Haunersches Kinderspital, Ludwig Maximilians University Munich, Department of Pediatric Gastroenterology and Hepatology, Munich, Germany